Skip to main content
Log in

Routine screening for hepatitis E in transplant recipients cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Ankcorn MJ, et al. Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation. Value in Health : 15 Nov 2019. Available from: URL: https://doi.org/10.1016/j.jval.2019.09.2751

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Routine screening for hepatitis E in transplant recipients cost effective. PharmacoEcon Outcomes News 842, 26 (2019). https://doi.org/10.1007/s40274-019-6418-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6418-0

Navigation